Treatment of complex infantile haemangioma in a resource-poor setting

Ronald Natawidjaja1, Ewen Wang2

  • 1Alam Sehat Lestari Clinic, West Kalimantan, Borneo, Indonesia.

BMJ Case Reports
|July 24, 2014
PubMed

Insights

Infantile haemangiomas, common vascular birthmarks, can cause serious complications. This case study shows oral propranolol effectively treated a severe infantile haemangioma in a resource-poor setting, resolving disfigurement and breathing issues.

Area of Science:

  • Pediatric Medicine
  • Dermatology
  • Vascular Biology

Background:

  • Infantile haemangiomas (IHs) are common benign vascular tumors affecting up to 5% of infants.
  • While most IHs resolve spontaneously, complex cases can lead to significant disfigurement or life-threatening complications.
  • IHs are often misperceived as surgical issues, delaying appropriate medical management.

Observation:

  • A case is presented of an infant in rural Indonesia with extensive facial IHs and suspected airway involvement causing stridor.
  • The infant presented with cosmetic disfigurement and respiratory distress.
  • The patient was from a resource-limited environment, highlighting access to care challenges.

Findings:

  • Treatment with oral propranolol resulted in significant regression of the cutaneous infantile haemangioma.
  • The infant's stridor resolved, indicating successful management of the airway haemangioma.
  • Propranolol administration also led to improved weight gain in the infant.

Implications:

  • Oral propranolol is an effective and accessible treatment for complex infantile haemangiomas, even in resource-poor settings.
  • This case underscores the importance of early medical intervention for IHs, particularly those with airway compromise.
  • Expanding access to propranolol treatment can improve outcomes for infants with severe infantile haemangiomas globally.

Related Concept Videos